China's CStone Pharmaceuticals H1 revenue soars on drug sales
China's CStone Pharmaceuticals H1 revenue soars on drug sales
Story updates
11:40:58 AM UTC
SquawkNews
CStone Pharmaceuticals: Revenue up 315% YoY, losses narrowed, and major clinical and commercial milestones achieved
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.